| 摘要 |
The present invention relates to estrogen receptor ligands, and compounds and methods for treating diseases associated with excessive estrogen receptor activity. Compound of the formula I are disclosed: wherein W is O or (CR<SUB>8</SUB>)<SUB>2</SUB>, and R<SUB>1 </SUB>to R<SUB>8</SUB>, Y, and m are defined as defined herein.
|
